RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own immune cells fight ovarian cancer? tiny trial aims to find out
Disease control Recruiting nowThis early-stage trial is testing whether a patient's own tumor-fighting immune cells (called TILs) can be safely used to treat recurrent ovarian cancer. Researchers take a sample of the tumor, grow the immune cells in a lab, and then inject them back into the patient. Only 6 peo…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: NA • Sponsor: Yong Wha Moon • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New antibody combo aims to fight back against recurrent ovarian cancer
Disease control Recruiting nowThis study is testing a new drug called ubamatamab, given alone or with another drug called cemiplimab, in people with ovarian cancer or other cancers that have come back after treatment. The main goals are to check safety, find the right dose, and see if the drugs can shrink tum…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for hard-to-treat ovarian cancer: combo therapy enters human trial
Disease control Recruiting nowThis study tests a new drug called CapsuleX combined with cisplatin in 40 people whose ovarian cancer no longer responds to platinum-based chemotherapy. The goal is to see if the combination can shrink tumors and how safe it is. Participants must have confirmed ovarian, fallopian…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can ashwagandha boost chemo in ovarian cancer? new trial aims to find out
Disease control Recruiting nowThis study tests adding Ashwagandha (an herbal supplement) to standard chemotherapy (DOXIL) for people whose ovarian cancer has returned. The goal is to find a safe dose and see if the combination helps shrink tumors or slow cancer growth. About 72 participants with recurrent ova…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sham Sunder Kakar • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can eye drops save sight during ovarian cancer treatment?
Symptom relief Recruiting nowThis phase 2 trial tests whether different eye drops can prevent or reduce eye problems caused by the cancer drug mirvetuximab soravtansine in 100 people with recurrent ovarian cancer. Participants will receive the cancer drug along with either lubricating drops, steroid drops, o…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New registry aims to learn from Real-World retreatment of gynecologic cancers
Knowledge-focused Recruiting nowThis observational registry is gathering data from 500 adults whose gynecologic cancer has returned after prior radiation therapy. Doctors are using reirradiation or other ablative strategies as part of standard care, and the registry will track how well these treatments control …
Matched conditions: RECURRENT OVARIAN CANCER
Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC